Actithera is a Biotech company based in Cambridge. It has raised $76M in total funding. Latest round: Series A.
Actithera funding overview
Actithera is a Biotech company based in Cambridge. Actithera has raised $76M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2025. The round record for Actithera runs through 2025; nothing later has been disclosed. Investors on record include M Ventures, Hadean Ventures, Sofinnova Partners, 4BIO Capital, Bioqube Ventures, Surveyor Capital and 3 others. 9 distinct backers are named across the disclosed rounds.
Actithera at a glance
Total raised
$76M
Latest round
Series A
Latest round date
July 2025
Industry
Biotech
Headquarters
Cambridge
Notable investors
M Ventures, Hadean Ventures, Sofinnova Partners, 4BIO Capital, Bioqube Ventures, Surveyor Capital, Innovestor's Life Science Fund, Investinor
Frequently asked about Actithera funding
How much has Actithera raised?
Actithera has raised $76M in total disclosed funding across the rounds on record.
Who has invested in Actithera?
M Ventures, Hadean Ventures, Sofinnova Partners, 4BIO Capital, Bioqube Ventures, Surveyor Capital are named among the investors backing Actithera.
What was the latest Actithera funding round?
The most recent disclosed round is a Series A, announced in July 2025.
Where is Actithera based?
Actithera is based in Cambridge.
What sector does Actithera operate in?
Actithera is tracked under Biotech from Cambridge, with $76M in disclosed funding.
When did Actithera last raise?
The last disclosed Actithera round closed in July 2025 at Series A.
We update the Actithera record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Cambridge and their backers are listed below.
